PNC0000003 - AdvaNced Technologies for Human-centrEd Medicine (project acronym: ANTHEM)
Retatrutide acts as a triple incretin receptor agonist, simultaneously activating three distinct receptors: GLP-1 receptors stimulating insulin secretion in a glucose-dependent manner, slowing gastric emptying, and reducing appetite GIP receptors enhancing insulin release and potentially improving fat metabolism Glucagon receptors increasing energy expenditure and promoting fat breakdown in the liver This multi-receptor activity produces pronounced effects on body weight, blood glucose, lipid metabolism, and hepatic fat
8 Agency EM
Week 2: If week 1 was tolerated well, increase to 50% of the target dose
By using a high concentration of hyaluronic acid, the Shine Face Serum can provide long-lasting hydration, leaving the skin feeling smooth and supple
The Precision Peptide Genetic Test from PlexusDx examines genetic variants in GIPR and FTO, and MC4R pathwaysmarkers that influence individual peptide sensitivity and metabolic response